• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MEN 2A和MEN 2B家族中RET原癌基因的双生殖系突变。

Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds.

作者信息

Dvorakova S, Vaclavikova E, Ryska A, Cap J, Vlcek P, Duskova J, Kodetova D, Holub V, Novak Z, Bendlova B

机构信息

Institute of Endocrinology, Department of Endokrinology, Prague 1, Czech Republic.

出版信息

Exp Clin Endocrinol Diabetes. 2006 Apr;114(4):192-6. doi: 10.1055/s-2006-924071.

DOI:10.1055/s-2006-924071
PMID:16705552
Abstract

Medullary thyroid carcinoma (MTC) is a rare form of thyroid cancer representing about 10% of all thyroid malignancies. It occurs mostly as a sporadic tumor or in association with autosomal dominant inherited cancer syndromes--multiple endocrine neoplasia (MEN) types 2A and 2B and familial MTC. Germline mutations in exons 8, 10, 11, 13, 14, 15 and 16 of the RET proto-oncogene are found in most of the familial cases. There are only a few published data reporting multiple germline mutations in the RET proto-oncogene. We have detected double germline mutations in 2 different exons on the same RET allele in two MEN 2 families. In the MEN 2A family, double germline mutation in exons 10 (Cys620Phe) and 13 (Tyr791Phe) was detected. In the MEN 2B family, beside the classical germline mutation in exon 16 (Met918Thr) a second germline mutation in exon 13 (Tyr791Phe) was found. This study revealed that MEN 2 syndromes can also be caused by double germline mutations in the RET proto-oncogene and these families can be added to small worldwide cohort of families with multiple germline mutations.

摘要

甲状腺髓样癌(MTC)是一种罕见的甲状腺癌形式,约占所有甲状腺恶性肿瘤的10%。它大多表现为散发性肿瘤,或与常染色体显性遗传癌症综合征——2A和2B型多发性内分泌腺瘤病(MEN)以及家族性MTC相关。大多数家族性病例中可发现RET原癌基因第8、10、11、13、14、15和16外显子的种系突变。仅有少数已发表的数据报道了RET原癌基因中的多种种系突变。我们在两个MEN 2家族的同一RET等位基因的2个不同外显子中检测到了双种系突变。在MEN 2A家族中,检测到第10外显子(Cys620Phe)和第13外显子(Tyr791Phe)的双种系突变。在MEN 2B家族中,除了第16外显子(Met918Thr)的经典种系突变外,还在第13外显子中发现了第二个种系突变(Tyr791Phe)。本研究表明,MEN 2综合征也可由RET原癌基因中的双种系突变引起,这些家族可被纳入全球范围内具有多种种系突变的小家族队列中。

相似文献

1
Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds.MEN 2A和MEN 2B家族中RET原癌基因的双生殖系突变。
Exp Clin Endocrinol Diabetes. 2006 Apr;114(4):192-6. doi: 10.1055/s-2006-924071.
2
RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.在患有MEN2A和MEN2B的中国大陆家系中,RET原癌基因突变仅限于密码子634和918。
Clin Endocrinol (Oxf). 2007 Oct;67(4):570-6. doi: 10.1111/j.1365-2265.2007.02927.x. Epub 2007 Jun 15.
3
Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.在源自葡萄牙中部地区的2型多发性内分泌腺瘤病家族及散发性甲状腺髓样癌病例中,RET原癌基因出现Cys611Tyr突变及一种新型的Arg886Trp替代。
Clin Endocrinol (Oxf). 2006 Jun;64(6):659-66. doi: 10.1111/j.1365-2265.2006.02524.x.
4
[Neural crest and multiple endocrinopathies].[神经嵴与多种内分泌病]
C R Seances Soc Biol Fil. 1996;190(5-6):557-67.
5
Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients.评估RET基因多态性/单倍型作为2型多发性内分泌腺瘤(MEN 2)修饰位点的作用,并分析其与一系列西班牙患者中RET突变类型的相关性。
Int J Mol Med. 2006 Apr;17(4):575-81.
6
Change in the spectrum of RET mutations diagnosed between 1994 and 2006.1994年至2006年间确诊的RET基因突变谱的变化。
Clin Lab. 2007;53(5-6):273-82.
7
[Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].[与RET原癌基因罕见种系突变相关的2型多发性内分泌肿瘤综合征家系的管理]
Klin Padiatr. 2004 Sep-Oct;216(5):270-6. doi: 10.1055/s-2004-44902.
8
[Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor].[甲状腺髓样肿瘤患者RET原癌基因突变分析]
Genetika. 2003 Jun;39(6):847-54.
9
[Hereditary medullary thyroid carcinoma--genotype-phenotype characterization].[遗传性甲状腺髓样癌——基因型-表型特征]
Dtsch Med Wochenschr. 2003 Sep 26;128(39):1998-2002. doi: 10.1055/s-2003-42555.
10
[The RET gene in multiple endocrine neoplasia type 2 (MEN 2)].[2型多发性内分泌腺瘤病(MEN 2)中的RET基因]
Nihon Rinsho. 2004 May;62(5):883-8.

引用本文的文献

1
Current status of the prognostic molecular markers in medullary thyroid carcinoma.甲状腺髓样癌预后分子标志物的现状
Endocr Connect. 2020 Dec;9(12):R251-R263. doi: 10.1530/EC-20-0374.
2
5P Strategies for Management of Multiple Endocrine Neoplasia Type 2: A Paradigm of Precision Medicine.5P 策略在 2 型多发性内分泌肿瘤管理中的应用:精准医学的范例。
Front Endocrinol (Lausanne). 2020 Sep 18;11:543246. doi: 10.3389/fendo.2020.543246. eCollection 2020.
3
Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
美国甲状腺协会修订的甲状腺髓样癌管理指南。
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
4
Tandem Germline RET Mutations in a Family Pathogenetic for Multiple Endocrine Neoplasia 2B, Confirmed by a Natural Experiment.家族性多发性内分泌肿瘤 2B 相关的串联种系 RET 突变,经自然实验证实。
Eur Thyroid J. 2014 Dec;3(4):272-7. doi: 10.1159/000369134. Epub 2014 Dec 3.
5
Comprehensive analysis of RET gene should be performed in patients with multiple endocrine neoplasia type 2 (MEN 2) syndrome and no apparent genotype-phenotype correlation: an appraisal of p.Y791F and p.C634Y RET mutations in five unrelated Brazilian families.应对多发性内分泌肿瘤 2 型(MEN 2)综合征患者进行 RET 基因的全面分析,且无明显的基因型-表型相关性:对 5 个无亲缘关系的巴西家族中的 p.Y791F 和 p.C634Y RET 突变的评估。
J Endocrinol Invest. 2013 Dec;36(11):975-81. doi: 10.3275/8997. Epub 2013 May 30.
6
RET mutation Tyr791Phe: the genetic cause of different diseases derived from neural crest.RET 基因突变 Tyr791Phe:源自神经嵴的不同疾病的遗传原因。
Endocrine. 2009 Dec;36(3):419-24. doi: 10.1007/s12020-009-9242-7. Epub 2009 Oct 14.
7
[Hereditary thyroid cancer].[遗传性甲状腺癌]
Chirurg. 2008 Nov;79(11):1017-28. doi: 10.1007/s00104-008-1558-y.